References
- 1
de Franchis R.
Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop
on definitions, methodology and therapeutic strategies in portal hypertension.
J Hepatol.
2000;
33
846-852
- 2
Moore K P, Wong F, Gines P. et al .
The management of ascites in cirrhosis: report on the consensus conference of the
International Ascites Club.
Hepatology.
2003;
38
258-266
- 3
Angermayr B, Cejna M, Peck-Radosavljevic M.
Management von Patienten vor und nach Implantation eines transjugulären intrahepatischen
portosystemischen Shunts (TIPS) - Bericht der Vienna TIPS Study Group.
Journal für Gastroenterologische und Hepatologische Erkrankungen.
2003;
1
11-14
- 4
Bosch J, Garcia-Pagan J C.
Complications of cirrhosis. I. Portal hypertension.
J Hepatol.
2000;
32
141-156
- 5
D’Amico G, Pagliaro L, Bosch J.
Pharmacological treatment of portal hypertension: an evidence-based approach.
Semin Liver Dis.
1999;
19
475-505
- 6
Merkel C, Bolognesi M, Sacerdoti D. et al .
The hemodynamic response to medical treatment of portal hypertension as a predictor
of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2000;
32
930-934
- 7
Abraldes J G, Tarantino I, Turnes J, Garcia-Pagan J C, Rodes J, Bosch J.
Hemodynamic response to pharmacological treatment of portal hypertension and long-term
prognosis of cirrhosis.
Hepatology.
2003;
37
902-908
- 8
Garcia-Pagan J C, Morillas R, Banares R. et al .
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention
of a first variceal bleed: a double-blind RCT.
Hepatology.
2003;
37
1260-1266
- 9
Schepke M, Kleber G, Nurnberg D. et al .
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2004;
40
65-72
- 10
Ben-Ari Z, Cardin F, McCormick A P, Wannamethee G, Burroughs A K.
A predictive model for failure to control bleeding during acute variceal haemorrhage.
J Hepatol.
1999;
31
443-450
- 11
Bernard B, Grange J D, Khac E N, Amiot X, Opolon P, Poynard T.
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients
with gastrointestinal bleeding: a meta-analysis.
Hepatology.
1999;
29
1655-1661
- 12
Moitinho E, Escorsell A, Bandi J C. et al .
Prognostic value of early measurements of portal pressure in acute variceal bleeding.
Gastroenterology.
1999;
117
626-631
- 13
Bureau C, Peron J M, Alric L. et al .
”A La Carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic
response for the prevention of bleeding.
Hepatology.
2002;
36
1361-1366
- 14
Cejna M, Peck-Radosavljevic M, Thurnher S. et al .
ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic
shunt.
Cardiovasc Intervent Radiol.
2002;
25
365-372
- 15
Angermayr B, Cejna M, Koenig F. et al .
Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered
stentgrafts versus bare stents.
Hepatology.
2003;
38
1043-1050
- 16
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L. et al .
Influence of portal hypertension and its early decompression by TIPS placement on
the outcome of variceal bleeding.
Hepatology.
2004;
40
793-801
- 17
Primignani M, Carpinelli L, Preatoni P. et al .
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis.
The New Italian Endoscopic Club for the study and treatment of esophageal varices
(NIEC).
Gastroenterology.
2000;
119
181-187
- 18
Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K.
Prevalence, classification and natural history of gastric varices: a long-term follow-up
study in 568 portal hypertension patients.
Hepatology.
1992;
16
1343-1349
- 19
Pache I, Bilodeau M.
Severe haemorrhage following abdominal paracentesis for ascites in patients with liver
disease.
Aliment Pharmacol Ther.
2005;
21
525-529
- 20
Gines P, Cardenas A, Arroyo V, Rodes J.
Management of cirrhosis and ascites.
N Engl J Med.
2004;
350
1646-1654
- 21
Rimola A, Garcia-Tsao G, Navasa M. et al .
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus
document. International Ascites Club.
J Hepatol.
2000;
32
142-153
- 22
Sort P, Navasa M, Arroyo V. et al .
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis
and spontaneous bacterial peritonitis.
N Engl J Med.
1999;
341
403-409
M. Peck-Radosavljevic, M. D.
Abteilung für Gastroenterologie und Hepatologie, Klinik Innere Medizin IV
Medizinische Universität Wien · Währinger Gürtel 18 - 20 · A-1090 Wien
Phone: +43-1-40400-6589 ·
Fax: +43-1-40400-4735
Email: Markus.peck@meduniwien.ac.at
